CTXR - CIK 0001506251
Citius Pharmaceuticals, Inc. trades as CTXR. This page tracks Citius Pharmaceuticals, Inc. through 625 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin compressed from -20769.9% to -37378.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Securities registration | S-3 | 2026-05-22 |
| Major company event | 8-K | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-15 |
| Major company event | 8-K | 2026-05-08 |
| Major company event | 8-K | 2026-04-29 |
| Major company event | 8-K | 2026-04-24 |
| Prospectus supplement | 424B5 | 2026-04-24 |
| Major company event | 8-K | 2026-04-06 |
The largest companies sharing Citius Pharmaceuticals, Inc.'s SEC industry classification (pharmaceutical preparations).
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.